Salloum et al., Cancer Res., (2000), 60(24), 6958-6963 Abstract Only.* |
Teicher et al., Radiat. Oncol. Invest., (1998), 6(2), 71-80 Abstract Only.* |
Kawai et al., Anticaner Res., (1998), 18(1A), 405-412 Abstract Only.* |
Nakashima et al., J. Antibiot., (1999), 52(4), 426-428 Abstract Only.* |
Teicher et al., “Optimal Scheduling of Interleukin-12 and Fractionated Radiation Therapy in the Murine Lewis Lung Carcinoma,” Radiation Oncology Investigations, 6:71-80, 1998. |
Kawai et al., Enhancement of Anticancer Effects of Radiation and Conventional Anticancer Agents by a Quniolinone derivative, Vesnarinone: Studies on Human Gastric Cancer Tissues in Nude Mice, Anticancer Res., 18:405-412, 1998. |
Voest et al., “Inhibition of Angiogenesis In Vivo by Interleukin 12,” J. Natl'l Cancer Inst., 87:581-586, 1995. |
Gorski et al., Blockade of the Vascular Endothelial Growth Factor Stress Response Increases the Antitumor Effects of Ionizing Radiation, Cancer Res., 59:3374-3378, 1999. |
Norioka et al., Interaction of Interleukin-1 and Interferon-g on Fibroblast Growth Factor-Induced Angiogenesis, Jpn. J. cancer Res., 85:522-529, 1994. |
Mauceri et al., “Combined effects of Angiostatin and Ionizing Radiation in Antitumor Therapy,” Nature, 394:287-291, 1998. |
Nakashima, et al., “Inhibition of Angiogenesis by a New Isocoumarin NM-3,” J. Antibiotics, 52:426-428, 1999. |
Kumagi, et al., “Antitumor Activity of Cytogenin,” J. Antibiotics, 48:175-178, 1995. |
Oikawa, et al., “Effects of Cytogenin, a Novel Microbial Product, on Embryonic and Tumor Cell-Induced Angiogenic Responses In Vivo,” Anticancer Res., 17:1881-1886, 1997. |